Onderneming Magle Chemoswed Holding AB (publ) Nasdaq Stockholm
Aandelen
SE0014401014
Farmaceutische producten
Vakgebied
Verkoop per activiteit
SEK in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Magle Chemoswed AB
90,4
%
| 119 | 90,1 % | 132 | 90,4 % | +10,56% |
PharmcaCept GmbH
11,6
%
| 11 | 8,0 % | 17 | 11,6 % | +59,32% |
Internal Eliminations
-11,1
%
| - | - | -16 | -11,1 % | - |
Magle Chemoswed Holding AB
6,8
%
| - | - | 10 | 6,8 % | - |
Adroit Science AB
2,3
%
| 2 | 1,9 % | 3 | 2,3 % | +35,06% |
Verkoop per regio
SEK in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Other
48,2
%
| 81 | 61,2 % | 70 | 48,2 % | -13,14% |
European Union excluding Sweden
43,1
%
| 14 | 10,9 % | 63 | 43,1 % | +335,26% |
Sweden
19,7
%
| 39 | 29,5 % | 29 | 19,7 % | -26,29% |
Internal Eliminations
-11,1
%
| - | - | -16 | -11,1 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Justin Pierce
CEO | Chief Executive Officer | 51 | 01-01-15 |
Petra Sjölin
DFI | Director of Finance/CFO | - | 01-07-20 |
Chief Operating Officer | 48 | 01-01-99 | |
Sales & Marketing | 48 | 30-09-22 | |
Simon Jegou
PRN | Corporate Officer/Principal | - | 01-01-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 78 | 01-01-16 | |
Director/Board Member | 79 | 01-01-16 | |
Director/Board Member | 44 | 01-01-20 | |
Founder | 78 | 01-01-94 | |
Malin Malmsjö
BRD | Director/Board Member | 51 | 01-01-16 |
Ingela Fritzon
BRD | Director/Board Member | 60 | 01-01-19 |
Martin Lidgard
BRD | Director/Board Member | 47 | 01-01-21 |
Claudia Lindwall
BRD | Director/Board Member | 61 | 01-01-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 10 800 000 | 2 310 488 ( 21,39 %) | 0 | 21,39 % |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+52,93% | 797 mld. | |
+40,55% | 628 mld. | |
-7,08% | 351 mld. | |
+17,40% | 323 mld. | |
+10,58% | 300 mld. | |
+17,13% | 244 mld. | |
+1,39% | 223 mld. | |
+6,24% | 163 mld. | |
-4,79% | 153 mld. |